Stockholm - Delayed Quote SEK

Elicera Therapeutics AB (publ) (ELIC.ST)

5.12
+0.72
+(16.36%)
At close: May 9 at 5:29:42 PM GMT+2
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
16,834.06
16,834.06
17,096.28
19,362.75
13,119.37
Operating Income
-16,834.06
-16,834.06
-17,096.28
-19,362.75
-13,119.37
Net Non Operating Interest Income Expense
773.73
773.73
698.30
-75.88
-1.08
Pretax Income
-16,110.33
-16,110.33
-16,397.98
-19,438.63
-13,120.44
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-16,110.33
-16,110.33
-16,397.98
-19,438.63
-13,120.44
Diluted NI Available to Com Stockholders
-16,110.33
-16,110.33
-16,397.98
-19,438.63
-13,120.44
Basic EPS
-0.51
-0.51
-0.83
-0.98
-0.82
Diluted EPS
-0.51
-0.51
-0.83
-0.98
-0.82
Basic Average Shares
31,588.88
31,588.88
19,756.60
19,835.34
16,000.54
Diluted Average Shares
31,588.88
31,588.88
19,756.60
19,835.34
16,000.54
Total Operating Income as Reported
-16,884.06
-16,884.06
-17,096.28
-19,362.75
-13,119.37
Total Expenses
16,834.06
16,834.06
17,096.28
19,362.75
13,119.37
Net Income from Continuing & Discontinued Operation
-16,110.33
-16,110.33
-16,397.98
-19,438.63
-13,120.44
Normalized Income
-16,110.33
-16,110.33
-16,397.98
-19,438.63
-13,120.44
Interest Income
826.53
826.53
774.19
53.46
0
Interest Expense
52.80
52.80
75.89
129.34
1.08
Net Interest Income
773.73
773.73
698.30
-75.88
-1.08
EBIT
-16,057.53
-16,057.53
-16,322.09
-19,309.29
-13,119.37
EBITDA
-16,045.75
-16,045.75
-16,310.31
-19,297.50
-13,107.59
Reconciled Depreciation
11.78
11.78
11.77
11.79
11.78
Net Income from Continuing Operation Net Minority Interest
-16,110.33
-16,110.33
-16,397.98
-19,438.63
-13,120.44
Normalized EBITDA
-16,045.75
-16,045.75
-16,310.31
-19,297.50
-13,107.59
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 6/11/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

XSPRAY.ST Xspray Pharma AB (publ)
32.10
-8.29%
 
1GDA.BE Zevra Therapeutics Inc
7.10
+6.77%
 
P0F.F Egetis Therapeutics AB (publ)
0.3085
+0.49%
 
ATORX.ST Alligator Bioscience AB (publ)
4.1500
+4.56%
 
CANTA.ST Cantargia AB (publ)
1.6300
+5.16%
 
BTPC.F Active Biotech AB (publ)
0.0060
-25.93%
 
ACE.ST Ascelia Pharma AB (publ)
3.8550
+1.58%
 
LPGO.ST Lipigon Pharmaceuticals AB (publ)
0.0936
+1.30%
 
ALZCUR.ST AlzeCure Pharma AB (publ)
2.5800
+1.57%
 
ABS.OL Arctic Bioscience AS
2.6000
-8.13%